A 70-year-old woman with angina pectoris developed a migrainous headache 3 days after starting oral propranolol. She had not complained of headaches since her second and third decade when she had suffered occasional attacks of migraine. It is likely that propranolol was the cause of her headache, since it recurred when she was rechallenged with the drug.
A 70-year-old woman with angina pectoris developed a migrainous headache 3 days after starting oral propranolol. She had not complained of headaches since her second and third decade when she had suffered occasional attacks of migraine. It is likely that propranolol was the cause of her headache, since it recurred when she was rechallenged with the drug.
Propranolol has been used in the treatment of migraine (B0rgesen et al., 1974; Wider0e and Vigander, 1974; Drug and Therapeutics Bulletin, 1975) , though the mode of action has not been elucidated. However, in the case reported here, propranolol appeared to precipitate vascular headaches. The patient was subsequently challenged with propranolol and placebo.
Case report A 70-year-old woman with a 20-year history of angina pectoris was admitted to hospital with severe persistent chest pain, occurring at rest, suggestive of myocardial ischaemia. A similar attack had occurred two months previously, but had been treated at home. She took nitroglycerin regularly in addition to thyroid replacement therapy for hypothyroidism. Although she had suffered from migraine (consisting of headache, visual disturbances, and vomiting) in her second and third decade, she had had no headaches for many years. Examination showed no abnormalities. The heart rate was 76/minute and the blood pressure was 130/70.
Investigations revealed normal haemoglobin, blood urea and electrolytes, liver function tests, serum levels of cardiac enzymes and thyroxine, and a normal chest x-ray film. Serial electrocardiograms were normal.
A She was discharged and remained well, apart from stable angina, requiring regular nitroglycerin; she had no further headaches.
Five months after discharge, the patient was rechallenged double-blind with propranolol and placebo, the first treatment being one tablet on day 1, one b.i.d. on day 2, and one t.d.s. for the rest of the week, the alternative treatment being similarly administered the following week. In week 1 (placebo), her angina remained stable and no headaches occurred. On day 5 of week 2 (propranolol 40 mg) the patient suffered a severe bilateral, frontal headache, lasting for 12 hours and associated with photophobia but no nausea. The following day she stopped taking the drug and the headache disappeared within 12 hours of the last dose. The trial was terminated in view of the distinct symptomatology.
Discussion
Propranolol appeared to precipitate vascular headaches in this patient, even though it is sometimes used for the prophylaxis of migraine (B0rgesen et al., 1974; Wider0e and Vigander, 1974; Drug and Therapeutics Bulletin, 1975 
